Sign In
Buy SYRE
Spyre Therapeutics Stock Insider Power
Based on the 100 latest insides trades, we have calculated the insider power to be negative at -97.98. In total, the insiders bought 2.31M and sold 5.16M SYRE shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
-97.98 |
| ● Buy | 2.31M shares |
| ● Sell | 5.16M shares |
|
43% Buy Activity
Strong Negative Correlation
|
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
Jun 01, 2026 Buy |
Burrows Scott L Chief Financial Officer |
7 500 Value: $108.8K |
||
|
Jun 01, 2026 Buy |
Burrows Scott L Chief Financial Officer |
7 500 Value: $108.8K |
||
|
Jun 01, 2026 Sell |
Burrows Scott L Chief Financial Officer |
1 801 Value: $125.6K |
||
|
Jun 01, 2026 Sell |
Burrows Scott L Chief Financial Officer |
2 599 Value: $183.9K |
||
|
Jun 01, 2026 Sell |
Burrows Scott L Chief Financial Officer |
3 100 Value: $223.4K |
||
|
May 27, 2026 Buy |
Fairmount Funds Management Llc Director |
8 026 Value: $582.0K |
||
|
May 27, 2026 Buy |
Albers Jeffrey W. Director |
8 026 Value: $582.0K |
||
|
May 27, 2026 Buy |
Henderson Michael Thomas Director |
8 026 Value: $582.0K |
||
|
May 27, 2026 Buy |
Stelzer Laurie Director |
8 026 Value: $582.0K |
||
|
May 27, 2026 Buy |
Mckenna Mark C. Director |
8 026 Value: $582.0K |
||
|
May 27, 2026 Buy |
Milligan Sandra Director |
8 026 Value: $582.0K |
||
|
May 08, 2026 Sell |
Henderson Michael Thomas Director |
2 404 Value: $174.5K |
||
|
May 08, 2026 Sell |
Henderson Michael Thomas Director |
33 513 Value: $2.47M |
||
|
May 08, 2026 Sell |
Henderson Michael Thomas Director |
24 814 Value: $1.86M |
||
|
May 08, 2026 Sell |
Henderson Michael Thomas Director |
19 269 Value: $1.45M |
||
|
May 01, 2026 Buy |
Burrows Scott L Chief Financial Officer |
12 500 Value: $181.3K |
||
|
May 01, 2026 Buy |
Burrows Scott L Chief Financial Officer |
12 500 Value: $181.3K |
||
|
May 01, 2026 Sell |
Burrows Scott L Chief Financial Officer |
12 500 Value: $892.1K |
||
|
May 01, 2026 Buy |
Sloan Sheldon Chief Medical Officer |
78 333 Value: $2.15M |
||
|
May 01, 2026 Buy |
Sloan Sheldon Chief Medical Officer |
78 333 Value: $2.15M |
||
|
May 01, 2026 Sell |
Sloan Sheldon Chief Medical Officer |
21 306 Value: $1.48M |
||
|
May 01, 2026 Sell |
Sloan Sheldon Chief Medical Officer |
19 656 Value: $1.39M |
||
|
May 01, 2026 Sell |
Sloan Sheldon Chief Medical Officer |
8 777 Value: $628.1K |
||
|
May 01, 2026 Sell |
Sloan Sheldon Chief Medical Officer |
12 777 Value: $932.0K |
||
|
May 01, 2026 Sell |
Sloan Sheldon Chief Medical Officer |
10 358 Value: $763.8K |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
